Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piekarska

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Acta Gastro-Enterologica Belgica|August 26, 2006
Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis CE Majda-Stanisławska, M Bednarek, B Jóźwiak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 15, 2011
The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infectionM Sidorkiewicz, M Brocka, M Bronis, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 29, 2009
[Memory hallucinations as an untypical symptom in schizoaffective disorders--legal doubts]Aneta M Sikora, Krzysztof A Kucia, Tomasz Medrala, et al.
Bone Marrow Transplantation|April 12, 2005
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host diseaseJ Balon, K Hałaburda, M Bieniaszewska, et al.
British Journal of Pharmacology|June 16, 2001
The vascular activity of some isoflavone metabolites: implications for a cardioprotective roleJ P Chin-Dusting, L J Fisher, T V Lewis, et al.
Transplantation Proceedings|August 7, 2016
Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia GroupJ Drozd-Sokołowska, L Gil, A Waszczuk-Gajda, et al.
Journal of Viral Hepatitis|June 12, 2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience studyR Flisiak, E Janczewska, M Łucejko, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
AIDS Care|July 27, 2019
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 studyA Piekarska, E Jabłonowska, A Garlicki, et al.
Journal of Viral Hepatitis|January 10, 2018
Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 studyR Flisiak, D Zarębska-Michaluk, E Janczewska, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Acta Gastro-Enterologica Belgica|August 26, 2006
Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis CE Majda-Stanisławska, M Bednarek, B Jóźwiak, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 15, 2011
The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infectionM Sidorkiewicz, M Brocka, M Bronis, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 29, 2009
[Memory hallucinations as an untypical symptom in schizoaffective disorders--legal doubts]Aneta M Sikora, Krzysztof A Kucia, Tomasz Medrala, et al.
Bone Marrow Transplantation|April 12, 2005
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host diseaseJ Balon, K Hałaburda, M Bieniaszewska, et al.
British Journal of Pharmacology|June 16, 2001
The vascular activity of some isoflavone metabolites: implications for a cardioprotective roleJ P Chin-Dusting, L J Fisher, T V Lewis, et al.
Transplantation Proceedings|August 7, 2016
Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia GroupJ Drozd-Sokołowska, L Gil, A Waszczuk-Gajda, et al.
Journal of Viral Hepatitis|June 12, 2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience studyR Flisiak, E Janczewska, M Łucejko, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
AIDS Care|July 27, 2019
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 studyA Piekarska, E Jabłonowska, A Garlicki, et al.
Journal of Viral Hepatitis|January 10, 2018
Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 studyR Flisiak, D Zarębska-Michaluk, E Janczewska, et al.
Pageof 2